According to this study, the global Generic Drugs market size will reach US$ 397400 million by 2031.
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
The generic drugs market is driven by the rising demand for cost-effective medications, especially as healthcare systems worldwide face increasing financial pressures. The expiration of patents on numerous blockbuster drugs opens opportunities for generic manufacturers to enter the market with more affordable alternatives. Additionally, supportive government policies, regulatory incentives, and growing acceptance of generics by healthcare providers and patients contribute to the market’s rapid expansion.
A key challenge in the generic drugs market is the intense price competition, which can squeeze profit margins and discourage innovation. Regulatory hurdles and delays in approval processes can also limit timely market entry. Furthermore, concerns about the quality and consistency of some generics—particularly in developing markets—may affect consumer trust and hinder adoption despite cost advantages.
The “Generic Drugs Industry Forecast” looks at past sales and reviews total world Generic Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Generic Drugs sales for 2025 through 2031. With Generic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Generic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Generic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Generic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Generic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Generic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Generic Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
Prescription
Non-Prescription Drugs
Segmentation by Application:
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Teva
Sandoz
Viatris
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
Pharmaniaga Berhad
Hovid Berhad
Duopharma Biotech
Kotra Pharma
HOE Pharmaceutical
Y.S.P. Industries
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Generic Drugs Market Size (2020-2031)
2.1.2 Generic Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Generic Drugs by Country/Region (2020, 2024 & 2031)
2.2 Generic Drugs Segment by Type
2.2.1 Prescription
2.2.2 Non-Prescription Drugs
2.3 Generic Drugs Market Size by Type
2.3.1 Generic Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Generic Drugs Market Size Market Share by Type (2020-2025)
2.4 Generic Drugs Segment by Application
2.4.1 CNS
2.4.2 Cardiovascular
2.4.3 Genitourinary/Hormonal Drugs
2.4.4 Respiratory
2.4.5 Rheumatology
2.4.6 Diabetes
2.4.7 Oncology
2.4.8 Others
2.5 Generic Drugs Market Size by Application
2.5.1 Generic Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Generic Drugs Market Size Market Share by Application (2020-2025)
3 Generic Drugs Market Size by Player
3.1 Generic Drugs Market Size Market Share by Player
3.1.1 Global Generic Drugs Revenue by Player (2020-2025)
3.1.2 Global Generic Drugs Revenue Market Share by Player (2020-2025)
3.2 Global Generic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Generic Drugs by Region
4.1 Generic Drugs Market Size by Region (2020-2025)
4.2 Global Generic Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Generic Drugs Market Size Growth (2020-2025)
4.4 APAC Generic Drugs Market Size Growth (2020-2025)
4.5 Europe Generic Drugs Market Size Growth (2020-2025)
4.6 Middle East & Africa Generic Drugs Market Size Growth (2020-2025)
5 Americas
5.1 Americas Generic Drugs Market Size by Country (2020-2025)
5.2 Americas Generic Drugs Market Size by Type (2020-2025)
5.3 Americas Generic Drugs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Generic Drugs Market Size by Region (2020-2025)
6.2 APAC Generic Drugs Market Size by Type (2020-2025)
6.3 APAC Generic Drugs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Generic Drugs Market Size by Country (2020-2025)
7.2 Europe Generic Drugs Market Size by Type (2020-2025)
7.3 Europe Generic Drugs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Generic Drugs by Region (2020-2025)
8.2 Middle East & Africa Generic Drugs Market Size by Type (2020-2025)
8.3 Middle East & Africa Generic Drugs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Generic Drugs Market Forecast
10.1 Global Generic Drugs Forecast by Region (2026-2031)
10.1.1 Global Generic Drugs Forecast by Region (2026-2031)
10.1.2 Americas Generic Drugs Forecast
10.1.3 APAC Generic Drugs Forecast
10.1.4 Europe Generic Drugs Forecast
10.1.5 Middle East & Africa Generic Drugs Forecast
10.2 Americas Generic Drugs Forecast by Country (2026-2031)
10.2.1 United States Market Generic Drugs Forecast
10.2.2 Canada Market Generic Drugs Forecast
10.2.3 Mexico Market Generic Drugs Forecast
10.2.4 Brazil Market Generic Drugs Forecast
10.3 APAC Generic Drugs Forecast by Region (2026-2031)
10.3.1 China Generic Drugs Market Forecast
10.3.2 Japan Market Generic Drugs Forecast
10.3.3 Korea Market Generic Drugs Forecast
10.3.4 Southeast Asia Market Generic Drugs Forecast
10.3.5 India Market Generic Drugs Forecast
10.3.6 Australia Market Generic Drugs Forecast
10.4 Europe Generic Drugs Forecast by Country (2026-2031)
10.4.1 Germany Market Generic Drugs Forecast
10.4.2 France Market Generic Drugs Forecast
10.4.3 UK Market Generic Drugs Forecast
10.4.4 Italy Market Generic Drugs Forecast
10.4.5 Russia Market Generic Drugs Forecast
10.5 Middle East & Africa Generic Drugs Forecast by Region (2026-2031)
10.5.1 Egypt Market Generic Drugs Forecast
10.5.2 South Africa Market Generic Drugs Forecast
10.5.3 Israel Market Generic Drugs Forecast
10.5.4 Turkey Market Generic Drugs Forecast
10.6 Global Generic Drugs Forecast by Type (2026-2031)
10.7 Global Generic Drugs Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Generic Drugs Forecast
11 Key Players Analysis
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Generic Drugs Product Offered
11.1.3 Teva Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Sandoz
11.2.1 Sandoz Company Information
11.2.2 Sandoz Generic Drugs Product Offered
11.2.3 Sandoz Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Sandoz Main Business Overview
11.2.5 Sandoz Latest Developments
11.3 Viatris
11.3.1 Viatris Company Information
11.3.2 Viatris Generic Drugs Product Offered
11.3.3 Viatris Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Viatris Main Business Overview
11.3.5 Viatris Latest Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Information
11.4.2 Sun Pharmaceutical Generic Drugs Product Offered
11.4.3 Sun Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Sun Pharmaceutical Main Business Overview
11.4.5 Sun Pharmaceutical Latest Developments
11.5 Aspen
11.5.1 Aspen Company Information
11.5.2 Aspen Generic Drugs Product Offered
11.5.3 Aspen Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Aspen Main Business Overview
11.5.5 Aspen Latest Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Information
11.6.2 Fresenius Kabi Generic Drugs Product Offered
11.6.3 Fresenius Kabi Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Fresenius Kabi Main Business Overview
11.6.5 Fresenius Kabi Latest Developments
11.7 Pfizer (Hospira)
11.7.1 Pfizer (Hospira) Company Information
11.7.2 Pfizer (Hospira) Generic Drugs Product Offered
11.7.3 Pfizer (Hospira) Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Pfizer (Hospira) Main Business Overview
11.7.5 Pfizer (Hospira) Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Generic Drugs Product Offered
11.8.3 Sanofi Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
11.9 Aurobindo
11.9.1 Aurobindo Company Information
11.9.2 Aurobindo Generic Drugs Product Offered
11.9.3 Aurobindo Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Aurobindo Main Business Overview
11.9.5 Aurobindo Latest Developments
11.10 Lupin
11.10.1 Lupin Company Information
11.10.2 Lupin Generic Drugs Product Offered
11.10.3 Lupin Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Lupin Main Business Overview
11.10.5 Lupin Latest Developments
11.11 Dr. Reddy's
11.11.1 Dr. Reddy's Company Information
11.11.2 Dr. Reddy's Generic Drugs Product Offered
11.11.3 Dr. Reddy's Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Dr. Reddy's Main Business Overview
11.11.5 Dr. Reddy's Latest Developments
11.12 Apotex
11.12.1 Apotex Company Information
11.12.2 Apotex Generic Drugs Product Offered
11.12.3 Apotex Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Apotex Main Business Overview
11.12.5 Apotex Latest Developments
11.13 Cipla
11.13.1 Cipla Company Information
11.13.2 Cipla Generic Drugs Product Offered
11.13.3 Cipla Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Cipla Main Business Overview
11.13.5 Cipla Latest Developments
11.14 ENDO (Par Pharmaceutical)
11.14.1 ENDO (Par Pharmaceutical) Company Information
11.14.2 ENDO (Par Pharmaceutical) Generic Drugs Product Offered
11.14.3 ENDO (Par Pharmaceutical) Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 ENDO (Par Pharmaceutical) Main Business Overview
11.14.5 ENDO (Par Pharmaceutical) Latest Developments
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Information
11.15.2 Stada Arzneimittel Generic Drugs Product Offered
11.15.3 Stada Arzneimittel Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Stada Arzneimittel Main Business Overview
11.15.5 Stada Arzneimittel Latest Developments
11.16 Krka Group
11.16.1 Krka Group Company Information
11.16.2 Krka Group Generic Drugs Product Offered
11.16.3 Krka Group Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Krka Group Main Business Overview
11.16.5 Krka Group Latest Developments
11.17 Nichi-Iko Pharmaceutical
11.17.1 Nichi-Iko Pharmaceutical Company Information
11.17.2 Nichi-Iko Pharmaceutical Generic Drugs Product Offered
11.17.3 Nichi-Iko Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Nichi-Iko Pharmaceutical Main Business Overview
11.17.5 Nichi-Iko Pharmaceutical Latest Developments
11.18 Valeant
11.18.1 Valeant Company Information
11.18.2 Valeant Generic Drugs Product Offered
11.18.3 Valeant Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Valeant Main Business Overview
11.18.5 Valeant Latest Developments
11.19 Zydus Cadila
11.19.1 Zydus Cadila Company Information
11.19.2 Zydus Cadila Generic Drugs Product Offered
11.19.3 Zydus Cadila Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Zydus Cadila Main Business Overview
11.19.5 Zydus Cadila Latest Developments
11.20 Hikma
11.20.1 Hikma Company Information
11.20.2 Hikma Generic Drugs Product Offered
11.20.3 Hikma Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Hikma Main Business Overview
11.20.5 Hikma Latest Developments
11.21 Pharmaniaga Berhad
11.21.1 Pharmaniaga Berhad Company Information
11.21.2 Pharmaniaga Berhad Generic Drugs Product Offered
11.21.3 Pharmaniaga Berhad Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Pharmaniaga Berhad Main Business Overview
11.21.5 Pharmaniaga Berhad Latest Developments
11.22 Hovid Berhad
11.22.1 Hovid Berhad Company Information
11.22.2 Hovid Berhad Generic Drugs Product Offered
11.22.3 Hovid Berhad Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Hovid Berhad Main Business Overview
11.22.5 Hovid Berhad Latest Developments
11.23 Duopharma Biotech
11.23.1 Duopharma Biotech Company Information
11.23.2 Duopharma Biotech Generic Drugs Product Offered
11.23.3 Duopharma Biotech Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 Duopharma Biotech Main Business Overview
11.23.5 Duopharma Biotech Latest Developments
11.24 Kotra Pharma
11.24.1 Kotra Pharma Company Information
11.24.2 Kotra Pharma Generic Drugs Product Offered
11.24.3 Kotra Pharma Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.24.4 Kotra Pharma Main Business Overview
11.24.5 Kotra Pharma Latest Developments
11.25 HOE Pharmaceutical
11.25.1 HOE Pharmaceutical Company Information
11.25.2 HOE Pharmaceutical Generic Drugs Product Offered
11.25.3 HOE Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.25.4 HOE Pharmaceutical Main Business Overview
11.25.5 HOE Pharmaceutical Latest Developments
11.26 Y.S.P. Industries
11.26.1 Y.S.P. Industries Company Information
11.26.2 Y.S.P. Industries Generic Drugs Product Offered
11.26.3 Y.S.P. Industries Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.26.4 Y.S.P. Industries Main Business Overview
11.26.5 Y.S.P. Industries Latest Developments
12 Research Findings and Conclusion
Ěý
Ěý
*If Applicable.
